NCT04201223Completed
Family Lifestyles, Actions, and Risk Education Intervention: Version 2
The FLARE Skin Cancer Prevention Intervention for Children of Melanoma Survivors
Source: ClinicalTrials.gov · Last updated 10 Jul 2026
Brief summary (registry, in English)
The overall purpose of this study is to determine the efficacy of the Family Lifestyles, Actions, and Risk Education (FLARE) intervention in improving melanoma preventive behaviors. Parent-child dyads, consisting of survivors of melanoma and their children, will be randomly assigned to either receive the FLARE intervention or standard education. Once enrolled, each parent-child dyad will participate in this study for just over 1 year. Both conditions will receive three bi-weekly live intervention sessions (30 minutes per session) with an interventionist, and quarterly boosters via text or email.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 752 (actual)
- First submitted
- 26 Nov 2019
- Start date
- 7 Apr 2020
- Primary completion date
- 28 Jan 2025
- Lead sponsor
- University of Utah
- Diseases
- Melanoma, Childhood cancers
- NCT number
- NCT04201223
What you commit to
- Study type: Interventional
- Participants enrolled: 752
- From 7 Apr 2020 to the primary completion date, 28 Jan 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Received testing for a mutation in CDKN2A/p16, including those who participated in a previous study where they received information on CDKN2A/p16.
Other illness
- Enrolled in a study led by an investigator at another institution, which also focuses on improving skin cancer prevention behaviors and utilizes the Utah Cancer Registry for study recruitment.
- Have only a history of ocular melanoma
Other
- Adults and children will be excluded from participation if they meet any of the following:
- Do not speak English
- Are unable to participate due to developmental delay
Who the study is looking for
- Adults are eligible for this trial if they:
- Are at least 18 years old AND
- Have been diagnosed with melanoma at any time in their life AND
- Have at least one biological child between the ages of 8-17 years who is able to participate in the trial with them.
- Children are eligible to participate with their parent if they:
- Are between the ages of 8-17 years AND
- Had at least 1 sunburn in the last 12 months AND
- Have at least one biological parent with a history of melanoma who can participate in the trial with them.
Age in the registry: 8 years to 110 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Huntsman Cancer Institute Coordinator of this site? Confirm its status | Salt Lake City | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.